| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10072213 | American Journal of Ophthalmology | 2005 | 6 Pages |
Abstract
Due to its anti-inflammatory potency and low rate of side effects, celecoxib is an effective drug for the treatment of diffuse anterior scleritis. Compared with other NSAIDs it shows minimal gastrointestinal side effects, so its high cost is justified. It represents an alternative drug therapy before systemic immunosuppressive treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Andrea M. MD, PhD, Christoph MD, PhD, Matthias D. MD, PhD,